As a spin-out from two leading UK universities, we understand the challenges researchers face; time and funding constraints, as well as the struggle to secure commercial partners for translational impact.
Vidiia empowers researchers with versatile tools for Laboratory, Field-Based, and Point-of-Care applications, helping you secure funding and attract commercial collaborations.
"Vidiia's Assay Accelerator and VH-Platform have enhanced the quality of our research projects and increased their commercial viability."
Dr. Averil Horton, Head of Business Development and Innovation, Brunel University
Revolutionising Diagnostics
Born from the need for rapid, cost-effective on-site testing during the COVID-19 pandemic, Vidiia transforms research into impactful diagnostics.
Leveraging AI-powered innovation, we aim to accelerate the development of 100 assays by 2029, making portable, affordable, and reliable testing accessible to all. Explore how we’re bridging the gap between discovery and real-world application to set new standards in diagnostic innovation.